Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study is to evaluate the safety and tolerability of itacitinib
in combination with docetaxel and to select doses for further evaluation (Part 1, safety
run-in portion).